Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cyxone selects first clinical site ahead of phase 1 study with T20K in MS

Cyxone AB (publ) announced today that the company has selected the clinical site that will carry out the drug candidate T20K's first in man study. The clinical site located in Western Europe has been carefully evaluated based on a number of crucial criteria and will treat the first healthy volunteers in the T20K clinical phase 1 study developed for the treatment of multiple sclerosis (MS). This means that the company is well aligned with the planned preparations for T20K's first clinical study prior to the start of recruitment of healthy volunteers as well as completion of the remaining

New immunological results that support intralymphatic treatment with Diamyd® to be presented at the Immunology of Diabetes Society Congress

New results of intralymphatic treatment with the diabetes vaccine Diamyd® indicate the induction of a long-term immune response that supports the positive clinical results shown in the DIAGNODE-1 trial. The results are presented this week at the international conference Immunology of Diabetes Society Congress 2018 in London."The results are encouraging and strengthen previously published immunological and clinical findings," says Rosaura Casas, Associate Professor of experimental pediatric immunology at Linköping University. “The most interesting finding is that intralymphatic treatment

Interim report 1 January – 30 September 2018

Interim report 1 January-30 September 2018 THIRD QUARTER (JULY-SEPTEMBER 2018) · Net turnover amounted to KSEK 0 (0) · Operating loss totalled KSEK -7,268 (-6,075) · Loss for the period totalled KSEK -7,318 (-6,068) · Cash flow from operating activities was KSEK -6,860 (-7,510) · Loss per share before dilution was SEK -0.35 (-0.31). Loss per share after dilution was SEK -0.25 (-0.18) PERIOD (JANUARY-SEPTEMBER 2018) · Net turnover amounted to KSEK 0 (0) · Operating loss totalled KSEK -23,065 (-14,010) · Loss for the period totalled KSEK -22,828 (-14,007) ·

Gunnebo Interim Report July - September 2018

Strong Growth and Continued StreamliningCEO Comments to Performance in the Quarter - Continuing OperationsDuring the third quarter, the Group’s organic growth was 6%, coming from the core Business Units Entrance Control, Safe Storage and Cash Management. Both Entrance Control and Safe Storage showed double-digit growth.  Entrance Control reported strong 17% sales growth for the quarter due to a very strong development of its business in all regions. Safe Storage also had strong sales growth for the quarter of 15%, mainly coming from the global ATM safes business and good development in

Change to Essity’s Executive Management Team

Margareta Lehmann, President of Health and Medical Solutions and a member of Essity’s Executive Management Team, is stepping down from her position due to retirement.Margareta Lehmann has held various positions at Essity since 1983 and has been a member of the Executive Management Team since 2011. She will step down from her position as President of Health and Medical Solutions on December 31, 2018 and will remain with the company in an advisory capacity during 2019. Her successor will be announced in due course.“Margareta has spent almost her entire career with Essity, and her

Hexagon strengthens its construction solutions portfolio for AEC (Architecture, Engineering, Construction) market with Bricsys acquisition

Hexagon AB, a global leader in digital solutions, today announced the acquisition of Bricsys, a fast-growing developer of CAD (computer-aided design) software that has been at the forefront of providing open, collaborative construction technology solutions since its founding in 2002.Its CAD platform, BricsCAD, supports 2D/3D general, mechanical, and sheet metal design and building information modelling (BIM) in one system. It’s 100% based on the de facto standard design format (.dwg), providing designers, engineers, and BIM professionals powerful access to the huge potential of vertical

STEEVE FÜHR WILL LEAVE THE POSITION AS CHIEF FINANCIAL OFFICER (CFO) FOR EDGEWARE AB

Press Release 23 OCTOBER 2017 Edgeware announced today that Steeve Führ will leave the position as Chief Financial Officer (CFO) at his own request for a new assignment with another employer."Steeve has been employed at Edgeware since 2015 and has been a committed, competent and appreciated CFO. Steeve has played a key role during the company's IPO process as well as in developing the company's finance department, financial management and administrative processes to a level that can be expected in a listed company. I would like to thank Steeve for his efforts and wish him luck in his

Lagercrantz Interim Report 2018/19 Q2

Second quarter (July – September 2018) · Net revenue increased by 15 percent to MSEK 895 (775). Organically, net revenue increased by 6 percent. · Operating profit (EBITA) increased by 19 percent to MSEK 117 (98), equivalent to an operating margin of 13.1 percent (12.6). · Profit after financial items increased by 23 percent to MSEK 96 (78). · Profit after taxes increased to MSEK 73 (62). Earnings per share before and after dilution for the latest 12-month period amounted to SEK 4.56, compared to SEK 4.21 for the 2017/18 financial year. · Return on equity was 22 percent (23)

AstraZeneca Extends Innate Pharma Collaboration

This announcement contains inside information 23 October 2018 07:00 BST [CBR issued at 06:00 BST] AstraZeneca strengthens and expands oncology developmentand commercialisation collaboration with Innate Pharma Full oncology rights to monalizumab Access to Innate Pharma's anti-CD39 monoclonal antibody,IPH5201, plus four additional immuno-oncology molecules Innate Pharma acquires US and EU rights to commercialise Lumoxiti Purchase of newly-issued 9.8% equity stake in Innate Pharma AstraZeneca, and its global biologics research and development arm MedImmune, today

Stora Enso’s Sustainability Report ranked among top ten globally

STORA ENSO OYJ PRESS RELEASE 23 October 2018 at 09.00 EESTStora Enso’s Sustainability Report 2017 has been included in the top ten sustainability reports globally according to the latest Reporting matters publication by the World Business Council for Sustainable Development (WBCSD). In WBCSD’s Reporting matters publication, Stora Enso’s Sustainability Report  is praised for its disclosure of internal sustainability management processes. The external assurance of

Fortum-Rusnano wind investment fund to start implementation of 200 MW project in Russia

FORTUM CORPORATION INVESTOR NEWS 23 OCTOBER 2018 9:00 EEST The Fortum-Rusnano wind investment fund has taken the investment decision for a 200-megawatt (MW) wind power project in Russia. The project is the second of the total 1,000 MW awarded to the fund in the Russian wind auction in June 2017. The wind farm is expected to start production during the first half of 2020. The first 50-MW project was started in late 2017 and is expected to start production during the first half of 2019. The Fortum-Rusnano wind investment fund is a 50/50 owned investment partnership to invest in wind

MQ recruits new Marketing Director from Volvo Cars

Mikael Kruse, currently Brand Communication Director EMEA at Volvo Cars, has been recruited as new Marketing Director at MQ starting February 1 2019. Mikael has a solid career in marketing that started at the sports brand Adidas global marketing department in Germany. He has also had several roles within Volvo Cars and, among other things, been the campaign manager for the attention-conscious Made by Sweden campaigns that Volvo made with Zlatan, Avicii, Robyn, Oscar Linnros and others. About taking the step to MQ he says: "For me, who was a teenager in the 90’s, MQ is a “Swedish

Ponsse’s Interim Report for 1 January – 30 September 2018

PONSSE PLC, STOCK EXCHANGE RELEASE, 23 OCTOBER 2018, 9:00 a.m.PONSSE’S INTERIM REPORT FOR 1 JANUARY – 30 SEPTEMBER 2018– Net sales amounted to EUR 415.9 (Q1-Q3/2017 398.3) million.– Q3 net sales amounted to EUR 124.8 (Q3/2017 139.6) million.– Operating result totalled EUR 39.3 (Q1-Q3/2017 46.8) million, equalling 9.5 (11.8) per cent of net sales.– Q3 operating result totalled EUR 9.9 (Q3/2017 18.6) million, equalling 7.9 (13.3) per cent of net sales.– Profit before taxes was EUR 34.3 (Q1-Q3/2017 40.4) million.– Cash flow from business operations was EUR 21.0 (20.7) million.–

Better third quarter than last year

Inwido's President and CEO, Håkan Jeppsson, comments on the third quarter of 2018:“It is pleasing to note that 25 of Inwido's 29 profit units performed better this quarter than in 2017, which is also reflected in operating profit having increased to SEK 202 million in the quarter, the most profit we have earned to date in any third quarter. However, the warm summer in the Nordic region generally dampened consumers' eagerness to buy, which led to increased competition in the windows industry and thereby pressure on gross margins. Inwido has coped with the challenging market situation pretty

Investor AB supports Saab’s planned rights issue

Saab today communicated a rights issue during the fourth quarter of about SEK 6 bn. Investor AB supports the company’s intention. “Saab is in a strong growth phase, with several major development projects in the order book. Recently the U.S. Air Force communicated its order of the T-X trainer aircraft, developed by Saab and Boeing. By strengthening its balance sheet, Saab will have the resources necessary to continue to develop these projects, invest in R&D, and create financial capacity for additional significant orders. As an engaged owner, we support our companies in sustainable value

BE Group Q3 2018 – Good growth and continued improved profitability

Third quarter · Net sales increased by 15% to SEK 1,111 M (968). · The underlying operating result increased to SEK 26 M (22). · The operating result increased to SEK 33 M (19). · Result after tax increased to SEK 23 M (9). · Cash flow from operating activities amounted to SEK -10 M (97). · Earnings per share increased to SEK 1.73 (0.72). Statement from the CEO In the third quarter, the business showed good growth and improved profitability compared to previous year, net sales increased by 15 percent. The underlying operating result improved by 22 percent, which is

Interim report January-September 2018

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU market abuse regulation. The information was submitted by the below contact persons for publication on 23 October 2018 at 7:45 a.m. CET. Better third quarter than last year Third quarter of 2018 · Net sales rose to SEK 1,682 million (1,559), representing an increase of 8 percent. Organic growth was a negative 1 percent · EBITA increased to SEK 200 million (172) after items affecting comparability of a negative SEK 2 million (0), and the EBITA margin grew to 11.9 percent (11.0) ·

Wärtsilä's Interim Report January-September 2018

Wärtsilä Corporation INTERIM REPORT 23 October 2018 at 8.30 a.m. local timeWärtsilä's Interim Report January-September 2018 GOOD DEVELOPMENT IN NET SALES This release is a summary of Wärtsilä’s Interim Report January-September 2018. The complete report is attached to this release as a pdf-file. It is also available at http://www.wartsilareports.com/en-US/2018/q3/frontpage/ and on the company website at www.wartsila.com. THIRD QUARTER HIGHLIGHTS - Order intake stable at EUR 1,372 million (1,354)- Net sales increased 13% to EUR 1,330 million (1,175)- Book-to-bill 1.03 (1.15)-

Interim Report January – September 2018

Hemfosa’s extraordinary general meeting on 13 September 2018 resolved in accordance with the proposal of the Board of Directors to distribute all shares in the subsidiary Nyfosa AB to Hemfosa’s ordinary shareholders. Accordingly, the information in this report refers to Hemfosa excluding Nyfosa (Continuing operations), unless otherwise stated. Nyfosa is recognized in this report as Operations to be distributed to shareholders in accordance with IFRS 5 and IFRIC 17. This means that Nyfosa’s profit for the period is recognized on a separate line in the consolidated statement of profit/loss and

Interim report Jan-Sep 2018: Strong quarter with increased earnings and historically low vacancies for Wihlborgs

· Rental income grew 16 percent to SEK 1,997 million (1,719) · Operating surplus increased 14 percent to SEK 1,462 million (1,277) · Income from property management rose 19 percent to SEK 1,051 million (884) · Profit for the period totalled SEK 1,469 million (1,495), corresponding to earnings per share of SEK 9.56 (9.73) · EPRA NAV per share amounts to SEK 120.58 kr (105.72).“Our earnings continue to improve and we can now sum up another excellent quarter. Income growth was driven by a combination of acquisitions, new production, rent increases and reduced vacancies. Our long-

TOMRA: Strong quarter fueled by high business activity in Sorting

TOMRA Systems ASA delivered strong results in the third quarter 2018, on the back of healthy growth in Tomra Collection Solutions and high business activity in Tomra Sorting Solutions.  Revenues in the third quarter 2018 ended at 2,247 MNOK, up 21% from 1,855 MNOK in third quarter last year. Organic, currency adjusted revenues were up 14% for the group, 9% for Tomra Collection Solutions and 20% for Tomra Sorting Solutions. Gross margin was 44% in the quarter, a slight increase from 43% in third quarter 2017, reflecting stable margins in Tomra Collection Solutions and improved margins

Q3 2018 Interim report January−September

Record Q3 sales & increased profitsQ3 2018 highlights · Record Q3 sales of SEK 4,683m (4,280) with 3% organic growth · Operating income before IAC of SEK 328m (257) including transaction costs related to the proposed split of MTG of SEK 7m [1] · Total operating income of SEK 340m (257) including items affecting comparability of SEK 12m [2] · Total net income of SEK 192m (177) including net income from discontinued operations of SEK -2m (-11) and total basic earnings per share of SEK 2.32 (2.31) · Net debt of SEK 3,085m (3,309) equivalent to 1.6x trailing EBITDA before IAC

Saab’s Results January-September 2018

Important Information  The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in Saab Aktiebolag (“Saab AB”) in any jurisdiction. All offers and sales of securities in connection with any rights offer by Saab AB will be made for certain eligible shareholders, subject to certain limited exceptions, outside of the United States and in reliance on, and in compliance with, Regulation S under the U.S. Securities Act of 1933, as amended. This press release may contain forward-

INTERIM REPORT JULY - SEPTEMBER 2018

STOCKHOLM, Sweden, October 23, 2018 Enea® (Nasdaq Stockholm: ENEA) A strong profit in the third quarter Third quarter 2018 ·  Revenue in the third quarter was SEK 209.6 (145.2) million, equivalent to a 44 percent increase. ·  Operating profit excluding non-recurring costs for the third quarter increased to SEK 51.9 (36.2) million, corresponding to an operating margin excluding non-recurring costs of 24.8 (24.9) percent. ·  Operating profit for the third quarter increased to SEK 51.2 (32.2) million, equivalent to an operating margin of 24.4 (22.2) percent. ·  Earnings per

There are no items matching the current filter
There are no more items matching the current filter
Back to top